Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
A highly selective fluorescent probe for real-time imaging of bacterial NAT2 and high-throughput screening of natural inhibitors for tuberculosis therapy
N
-Acetyltransferase 2 (NAT2) is a very important biologically functioning enzyme which plays a key role in the synthesis of cell walls in slowly growing mycobacteria. Thus, it has been widely considered to be a drug-target for anti-mycobacterial therapy. Herein, based on its catalytic characteristics,
ARHB
was developed for the real-time monitoring and assessment of the activity of NAT2 in different bacteria such as
Mycobacterium
,
Staphylococcus aureus
,
Lactobacillus
, and
Pseudomonas aeruginosa
. Moreover, using the highly sensitive probe
ARHB
, a potent natural inhibitor (
KSB-4
) of NAT2 was found which could effectively inhibit
Mycobacterium tuberculosis
H37Ra for the first time. Furthermore, the bioactivity of
KSB-4
for treating tuberculosis was also evaluated in
M. tuberculosis
H37Ra, showing a minimum inhibitory concentration (MIC) of 25 μM. After treatment with
KSB-4
,
M. tuberculosis
H37Ra grew to be much shorter and its cell wall lysis was observed in scanning electron micrographs. All of the results fully demonstrated that
ARHB
could serve as a promising molecular tool for the rapid and real-time detection of NAT2 activity in a complex system, providing a novel high-throughput screening method for the discovery of new NAT2 inhibitors.